![Arnd Christ](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arnd Christ
Fondateur chez
Cf Port GmbH
Profil
Arnd Christ is the founder of Cf Port GmbH.
Current jobs include Chief Financial Officer at Immatics Biotechnologies GmbH since 2020 and Chief Financial Officer at Immatics NV from 2020 to 2025.
Former jobs include Finance Director at Avery Dennison Corp.
from 2000 to 2001, Finance Director at Hoechst AG in 1999, Finance Director at Avery Dennison GmbH from 2000 to 2001, Chief Financial Officer at MediGene AG from 2010 to 2012, Chief Financial Officer at Vivoryon Therapeutics NV from 2002 to 2007, Chief Financial Officer at NovImmune SA from 2007 to 2010, Chief Financial Officer at Proteros biostructures GmbH from 2012 to 2014, Chief Financial Officer at EleGene AG from 2001 to 2002, and Chief Financial Officer at InflaRx NV from 2015 to 2020.
Education includes an MBA from Boston University and an MBA from Wuerzburg Schweinfurt University of Applied Sciences.
Postes actifs de Arnd Christ
| Sociétés | Poste | Début |
|---|---|---|
Cf Port GmbH | Fondateur | - |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Directeur Financier/CFO | 01/01/2020 |
Anciens postes connus de Arnd Christ
| Sociétés | Poste | Fin |
|---|---|---|
| IMMATICS N.V. | Directeur Financier/CFO | 01/10/2025 |
| INFLARX N.V. | Directeur Financier/CFO | 01/10/2020 |
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Serves as a discovery service business | Directeur Financier/CFO | 01/01/2014 |
| MEDIGENE AG | Directeur Financier/CFO | 19/09/2012 |
| NOVIMMUNE SA | Directeur Financier/CFO | 01/01/2010 |
Formation de Arnd Christ
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
35
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Avery Dennison Corp.
 Avery Dennison Corp. Pulp & PaperProcess Industries Designs and develops labeling and functional materials, radio frequency identification inlays, tags & software applications | Process Industries |
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Process Industries |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
Wuerzburg Schweinfurt University of Applied Sciences
 Wuerzburg Schweinfurt University of Applied Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Novimmune SA
 Novimmune SA BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Proteros biostructures GmbH
Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Serves as a discovery service business | Health Services |
EleGene AG | |
InflaRx NV
 InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Cf Port GmbH | |
Avery Dennison GmbH | |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
